As Reported Financial Statements

As Reported Financials

Balance Sheet
Cashflow Statement

Document Name As Of Date Currency Code (in units)	2016 Y 10-K 12/31/2016 USD	2017 Y 10-K 12/31/2017 USD	2018 Y 10-K 12/31/2018 USD	2019 Y 10-K 12/31/2019 USD	2020 Q1 YTD 10-Q 3/31/2020 USD
Document Name As Of Date Currency Code	2016 Y 10-K 12/31/2016 USD	2017 Y 10-K 12/31/2017 USD	2018 Y 10-K 12/31/2018 USD	2019 Y 10-K 12/31/2019 USD	2020 Q1 YTD 10-Q 3/31/2020 USD
Cash flows from operating activities
Net income	31,913,000	31,274,000	42,024,000	49,456,000	10,673,000
Adjustments to reconcile net income to net cash from operating activities
Depreciation and amortization	9,576,000	10,358,000	9,766,000	9,553,000	982,000
Accretion of acquired loans	(4,925,000)	(2,338,000)	(1,373,000)	(686,000)	(113,000)
Provision for loan losses	2,900,000	2,950,000	1,100,000	1,750,000	750,000
Deferred income tax expense (benefit)	(812,000)	831,000	(372,000)	26,000	NA
Stock-based compensation expense	1,459,000	1,981,000	2,410,000	2,931,000	625,000
Stock grants to directors for retainer fee	327,000	363,000	441,000	375,000	NA
Proceeds from sales of mortgage loans held for sale	114,757,000	111,311,000	101,146,000	261,021,000	68,627,000
Origination of mortgage loans held for sale	(110,778,000)	(108,857,000)	(96,179,000)	(256,767,000)	(86,206,000)
Net gain from sales of mortgage loans held for sale	(3,699,000)	(3,972,000)	(3,536,000)	(8,108,000)	(2,096,000)
Gain on trust preferred securities repurchase	(2,970,000)	NA	NA	NA	NA
Net gain from sales and valuation write-downs of foreclosed assets	(520,000)	(319,000)	(169,000)	(254,000)	(49,000)
Net gain from sales and valuation write-downs of former bank premises	35,000	133,000	(78,000)	(436,000)	(27,000)
Net loss from sales and write-downs of fixed assets	174,000	71,000	134,000	294,000	54,000
Net gain from sales of available for sale securities	1,000	(37,000)	0	0	NA
Earnings on bank owned life insurance	(1,264,000)	(2,731,000)	(1,287,000)	(3,886,000)	(336,000)
Net change in
Accrued interest receivable	122,000	(1,056,000)	(1,126,000)	(48,000)	220,000
Other assets	(648,000)	(354,000)	(2,193,000)	(7,636,000)	271,000
Accrued interest and other liabilities	(1,046,000)	(943,000)	11,029,000	(2,818,000)	(3,153,000)
Net cash from/(for) operating activities	34,602,000	38,665,000	61,737,000	44,767,000	(9,778,000)
Cash flows from investing activities
Loan originations and payments, net	(97,282,000)	(178,373,000)	(193,556,000)	(99,620,000)	(24,910,000)
Purchases of securities available for sale	(164,336,000)	(67,027,000)	(48,664,000)	(62,084,000)	(99,002,000)
Proceeds from maturities, calls and repayments of securities available for sale	172,173,000	52,504,000	40,308,000	79,478,000	124,510,000
Proceeds from sales of securities available for sale	264,000	7,619,000	0	0	NA
Purchases of Federal Home Loan Bank stock	(459,000)	(3,010,000)	(4,986,000)	(1,980,000)	0
Proceeds from sales of foreclosed assets	2,059,000	993,000	772,000	790,000	106,000
Proceeds from sales of former bank premises	45,000	25,000	1,964,000	854,000	162,000
Proceeds from bank owned life insurance cash value release and death benefits	0	2,720,000	0	7,708,000	0
Purchases of bank owned life insurance	(7,000,000)	(1,500,000)	0	(4,500,000)	0
Net purchases of premises and equipment	(2,025,000)	(5,423,000)	(6,318,000)	(13,484,000)	(3,159,000)
Net cash for investing activities	(96,561,000)	(191,472,000)	(210,480,000)	(92,838,000)	(2,293,000)
Cash flows from financing activities
Net increase (decrease) in time deposits	(20,854,000)	(55,839,000)	(30,091,000)	170,921,000	(61,810,000)
Net increase (decrease) in all other deposits	120,457,000	203,219,000	(28,566,000)	55,755,000	16,842,000
Net increase in securities sold under agreements to repurchase	(23,061,000)	(12,962,000)	(15,229,000)	(844,000)	30,595,000
Maturities of Federal Home Loan Bank advances	(3,000,000)	(45,000,000)	(30,000,000)	(40,000,000)	0
Proceeds from Federal Home Loan Bank advances	110,000,000	90,000,000	160,000,000	44,000,000	40,000,000
Proceeds from stock option exercises	978,000	318,000	108,000	128,000	0
Employee stock purchase plan	36,000	46,000	52,000	50,000	14,000
Dividend reinvestment plan	1,601,000	1,576,000	1,165,000	729,000	192,000
Repurchases of common stock	(3,732,000)	0	(5,943,000)	(7,183,000)	(6,282,000)
Repurchase of trust preferred securities	(8,030,000)	NA	NA	NA	NA
Payment of cash dividends to common shareholders	(18,731,000)	(12,046,000)	(27,500,000)	(17,108,000)	(4,492,000)
Net cash from financing activities	155,664,000	169,312,000	23,996,000	206,448,000	15,059,000
Net change in cash and cash equivalents	93,705,000	16,505,000	(124,747,000)	158,377,000	2,988,000
Cash and cash equivalents at beginning of period	89,891,000	183,596,000	200,101,000	75,354,000	233,731,000
Cash and cash equivalents at end of period	183,596,000	200,101,000	75,354,000	233,731,000	236,719,000
Supplemental disclosures of cash flows information
Cash paid during the period for
Interest	12,477,000	15,468,000	21,569,000	32,103,000	8,290,000
Federal income tax	15,125,000	14,225,000	10,075,000	11,975,000	0
Noncash financing and investing activities
Transfers from loans to foreclosed assets	414,000	887,000	744,000	337,000	11,000
Transfers from bank premises to other real estate owned	381,000	1,736,000	296,000	258,000	0

Data shown on this page is extracted directly from the company’s documents. S&P makes every effort to line up fields, captions and headers that represent the same data over time, despite variations in how the company may report these items in different documents. In certain instances the variation in the company’s presentation over time may be too significant, potentially resulting in repeating and/or disordered items. Despite possible issues with the presentation, S&P, as always, stands by its commitment to the quality of the data.

As Reported Financials

Cashflow Statement

Cash flows from operating activities

Adjustments to reconcile net income to net cash from operating activities

Cash flows from investing activities

Cash flows from financing activities

Supplemental disclosures of cash flows information

Cash paid during the period for

Noncash financing and investing activities